Sartorius | SRT3 - Ordinary Share Capital

Stock Price
209.70
Daily Change
-5.30 -2.47%
Monthly
-7.21%
Yearly
-15.27%
Q1 Forecast
203.68

Sartorius reported EUR69.04M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 2K 0 Mar/2025
Alaunos Therapeutics USD 2.21M 2.2M Sep/2025
Dianthus Therapeutics USD 42.85M 42.82M Sep/2025
Ionis Pharmaceuticals USD 161.97M 836K Dec/2025
IQVIA Holdings USD 169.6M 700K Dec/2025
Moderna USD 391M 2M Sep/2025
Organon & Co USD 259.98M 18K Sep/2025
Revvity USD 113.38M 2.7M Dec/2025
Sartorius EUR 69.04M 0 Sep/2025
Tectonic Therapeutic USD 14.86M 111.83K Dec/2024
Viatris USD 1.16B 6.55M Sep/2025
Xeris Pharmaceuticals USD 165.53M 165.51M Sep/2025